Zemplényi A - Search Results

1

Can cost-effectiveness principles be ignored in urgent times?

Kaló Z, Németh B, Zemplényi A. Kaló Z, et al. Among authors: zemplenyi a. J Comp Eff Res. 2022 Jan;11(1):7-9. doi: 10.2217/cer-2021-0211. Epub 2021 Oct 20. J Comp Eff Res. 2022. PMID: 34668766 Free PMC article. No abstract available.

2

Cost-effectiveness analysis of intensity-modulated radiation therapy with normal and hypofractionated schemes for the treatment of localised prostate cancer.

Zemplényi AT, Kaló Z, Kovács G, Farkas R, Beöthe T, Bányai D, Sebestyén Z, Endrei D, Boncz I, Mangel L. Zemplényi AT, et al. Eur J Cancer Care (Engl). 2018 Jan;27(1). doi: 10.1111/ecc.12430. Epub 2016 Jan 19. Eur J Cancer Care (Engl). 2018. PMID: 26782759 Review.

3

[A microcost analysis of radiation therapy of localized prostate cancer].

Zemplényi AT, Mangel L, Kaló Z, Endrei D, Boncz I. Zemplényi AT, et al. Orv Hetil. 2016 Mar 20;157(12):461-8. doi: 10.1556/650.2016.30392. Orv Hetil. 2016. PMID: 26971646 Hungarian.

4

[Meta-analysis of the side-effect profiles of modern radiation therapies for patients with prostate cancer].

Zemplényi AT, Mangel L, Kaló Z, Endrei D, Lohner S, Boncz I. Zemplényi AT, et al. Orv Hetil. 2016 May 15;157(20):776-88. doi: 10.1556/650.2016.30422. Orv Hetil. 2016. PMID: 27156525 Hungarian.

5

Comparative Cost-Effectiveness Study of Modern Radiation Therapies in Hungary for Localized Prostate Cancer.

Zemplényi A, Kalo Z, Mangel L, Endrei D, Boncz I. Zemplényi A, et al. Value Health. 2014 Nov;17(7):A636. doi: 10.1016/j.jval.2014.08.2282. Epub 2014 Oct 26. Value Health. 2014. PMID: 27202266 Free article. No abstract available.

6

Direct healthcare cost of schizophrenia - European overview.

Kovács G, Almási T, Millier A, Toumi M, Horváth M, Kóczián K, Götze Á, Kaló Z, Zemplényi AT. Kovács G, et al. Among authors: zemplenyi at. Eur Psychiatry. 2018 Feb;48:79-92. doi: 10.1016/j.eurpsy.2017.10.008. Epub 2018 Feb 3. Eur Psychiatry. 2018. PMID: 29428166 Review.

7

Behind the subcutaneous trastuzumab hype: evaluation of benefits and their transferability to Central Eastern European countries.

Inotai A, Ágh T, Karpenko AW, Zemplényi A, Kaló Z. Inotai A, et al. Among authors: zemplenyi a. Expert Rev Pharmacoecon Outcomes Res. 2019 Apr;19(2):105-113. doi: 10.1080/14737167.2019.1554437. Epub 2018 Dec 7. Expert Rev Pharmacoecon Outcomes Res. 2019. PMID: 30488730 Review.

8

Planning, implementation and operation of a personalized patient management system for subjects with first suspect of cancer (OnkoNetwork): system description based on a qualitative study.

Pitter JG, Csanádi M, Szigeti A, Lukács G, Kovács Á, Moizs M, Repa I, Zemplényi A, Czypionka T, Kraus M, Rutten-van Mölken MPMH, Kaló Z. Pitter JG, et al. Among authors: zemplenyi a. BMC Health Serv Res. 2019 Feb 21;19(1):131. doi: 10.1186/s12913-019-3957-9. BMC Health Serv Res. 2019. PMID: 30791917 Free PMC article.

9

Implementation of palliative care consult Service in Hungary - integration barriers and facilitators.

Zemplényi AT, Csikós Á, Csanádi M, Mölken MR, Hernandez C, Pitter JG, Czypionka T, Kraus M, Kaló Z. Zemplényi AT, et al. BMC Palliat Care. 2020 Mar 27;19(1):41. doi: 10.1186/s12904-020-00541-0. BMC Palliat Care. 2020. PMID: 32220251 Free PMC article.

10

Development of transferability guidance for integrated care models with special focus on Central and Eastern European countries.

Kaló Z, Zemplényi A, Rutten-van Mölken M, Looman W, Huić M, Tandara Haček R, Petrova G, Piniazhko O, Tesar T, Csanádi M, Pitter JG. Kaló Z, et al. Among authors: zemplenyi a. Croat Med J. 2020 Jul 5;61(3):252-259. doi: 10.3325/cmj.2020.61.252. Croat Med J. 2020. PMID: 32643342 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters